EUS-guided percutaneous intra-tumor injection of ethanol on orthotopic human pancreatic cancer model in mice

张文颖,吴红玉,郭杰芳,郭妍,刘晓,龚艳芳,高军,金震东,李兆申

DOI: https://doi.org/10.3760/cma.j.issn.1007-5232.2013.04.002

2013-01-01

Abstract:Objective To study the efficacy of EUS-guided percutaneous ethanol intra-tumor injection on orthotopic human pancreatic cancer mice model.Methods Twenty nude mice with orthotopic transplantation of human pancreatic cancer were randomly divided into 2 groups to receive 95％ ethanol intratumor injection or normal saline intra-tumor injection.The serum amylase levels were detected before and 24h after treatment.Tumor sizes were measured by high-frequency EUS (75 MHz) before and 7d after treatment.Relative tumor volume and relative rate of tumor proliferation were calculated.Histological changes of tumor tissue were observed by an optical microscope before and 7d after treatment.Results The serum amylase in experimental group was slightly elevated 24h after treatment [(2873.5 ± 958.9)vs.(2004.3 ±402.0),P ＞ 0.05],but no significant difference was seen when compared with that of the control group (2066.1 ±396.6,P =0.061).Relative tumor volume at 7th day after injection in experimental group was significantly lower than that of control group (0.45 ±0.08 vs.1.25 ±0.06,P ＜0.01).The relative rate of tumor proliferation at 7th day after injection was 36％ in experimental group.The massive coagulation necrosis was seen at 7th day after injection in experimental group,while only minor necrosis was observed in control group.Conclusion EUS-guided percutaneous intra-tumor injection of 95％ ethanol can lead to tumor necrosis,and have a therapeutic effect in orthotopic pancreatic cancer nude model.